Suchergebnisse - "Dejnirattisai, Wanwisa"

PubPharm (116)

1

Analysis of emergent bivalent antibody binding identifies the molecular reach as a critical determinant of SARS-CoV-2 neutralisation potency

enthalten in: bioRxiv.org | 2024

von Huhn, A. | Nissley, D. | Wilson, D. | +16

2

The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86

enthalten in: Nature communications | 2024

von Zhou, D. | Supasa, P. | Liu, C. | +14

3

Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population

enthalten in: Nature communications | 2024

von Wei, J. | Stoesser, N. | Matthews, P. | +71

4

Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera

enthalten in: bioRxiv.org | 2023

von Mühlemann, B. | Wilks, S. | Baracco, L. | +43

5

Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera

enthalten in: bioRxiv : the preprint server for biology | 2023

von Mühlemann, B. | Wilks, S. | Baracco, L. | +43

6

Accelerating drug target inhibitor discovery with a deep generative foundation model

enthalten in: Science advances | 2023

von Chenthamarakshan, V. | Hoffman, S. | Owen, C. | +17

7

COVID-19 vaccination, risk-compensatory behaviours, and contacts in the UK

enthalten in: Scientific reports | 2023

von Buckell, J. | Jones, J. | Matthews, P. | +65

8

Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK

enthalten in: Nature communications | 2023

von Wei, J. | Matthews, P. | Stoesser, N. | +75

9

Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK : Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511

enthalten in: The Journal of infection | 2023

von Liu, X. | Munro, A. | Feng, S. | +56

ErratumFor: J Infect. 2022 Jun;84(6):795-813. - PMID 35405168

10

Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens

enthalten in: Med (New York, N.Y.) | 2023

von Moore, S. | Kronsteiner, B. | Longet, S. | +62

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]